Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$930,258
-$137,680 QoQ
Shares Held
38,632
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,370
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHEAST INVESTMENT MANAGEMENT holds $126,194,934 across 8 Drug Manufacturers - General names. PFE ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,340 | $65,177,031 | |
| 2 | JNJ |
Johnson & Johnson
|
170,118 | $43,204,868 | |
| 3 | MRK |
Merck & Co., Inc.
|
57,478 | $7,385,923 | |
| 4 | NVS |
Novartis AG
|
27,819 | $4,359,793 | |
| 5 | ABBV |
AbbVie Inc.
|
12,037 | $3,028,990 | |
| 6 | AMGN |
Amgen Inc
|
4,802 | $1,738,900 | |
| 7 | PFE |
Pfizer Inc
This page
|
38,632 | $930,258 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,407 | $369,171 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $930,258 | 38,632 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,067,938 | 38,032 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $947,718 | 38,061 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $998,739 | 39,197 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,082,340 | 44,651 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,395,144 | 55,057 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,687,467 | 63,606 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,896,865 | 100,099 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,953,512 | 105,558 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,617,628 | 130,365 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $4,908,263 | 170,485 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $8,532,319 | 257,230 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,075,079 | 274,675 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $11,544,564 | 282,955 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $14,555,541 | 284,066 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $12,674,821 | 289,644 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $16,748,081 | 319,437 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $15,595,246 | 301,241 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $17,227,896 | 291,751 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $10,603,556 | 246,537 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $8,974,962 | 229,187 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,189,714 | 170,845 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $6,178,926 | 167,860 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,042,795 | 164,654 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,780,221 | 146,184 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,809,334 | 147,345 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||